Steven Cohen’s United Therapeutics UTHR Stock Holding History

Steven Cohen’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,600	Closed	-$6.29M	–	4615
2026 Q1	$6.29M	Buy	+10,600	New	+$5.28M	0.01%	1545

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Steven Cohen's UTHR Position: Q2 2026 in Review

Steven Cohen increased its United Therapeutics (UTHR) stake by 35% in Q2 2026, buying an estimated $29.2M and bringing the position to 201,159 shares worth $109M. The position accounts for 0.12% of the portfolio, ranked #181.

Steven Cohen first reported a position in UTHR in Q3 2014 and has held it in 23 quarters since. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Steven Cohen held 201,159 shares of United Therapeutics worth $109M as of Q2 2026.
Steven Cohen bought 51,856 United Therapeutics shares in Q2 2026, an estimated $29.2M.
United Therapeutics made up 0.12% of Steven Cohen's portfolio in Q2 2026, its #181 holding.
Steven Cohen first reported a position in United Therapeutics in Q3 2014 and has held it in 23 quarters since.
874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.